Amarin Corporation plc - 예탁증서(보통주)
US ˙ NasdaqCM ˙ US0231112063

소개

이 페이지에서는 OrbiMed Capital GP III LLC의 공개된 내부자의 매매 거래 내역을 종합적으로 분석합니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다. 이러한 제한에도 불구하고, 학계 연구에 따르면 내부자는, 일반적으로, 자신의 회사 주식에 대한 실적이 시장의 수익률을 능가하는 경향성을 보였습니다.

평균 거래 수익성

평균 거래 수익성은 내부자가 지난 3년 동안 매입한 모든 "공개 시장"(Open market)에서의 매입의 평균 수익률입니다. 이를 계산하기 위해 10b5-1 거래 계획의 일부로 표시된 모든 거래를 제외하고 내부자가 계획되지 않은 모든 오픈 마켓에서의 매입을 조사합니다. 그런 다음 3개월, 6개월, 12개월 동안 해당 거래의 평균 성과를 계산하여 각 거래에 대한 최종 성과 지표를 생성합니다. 마지막으로 내부자에 대한 성과 지표를 계산하기 위해 모든 성과 지표의 평균을 내립니다. 이 목록에는 지난 2년 동안 최소 3번 이상 거래한 내부자만 포함됩니다.

내부자의 매매 거래 수익성이 "해당 없음"인 경우, 내부자는 지난 3년 동안 공개 시장에서 매수한 적이 없거나, 거래가 너무 최근에 이루어져서 신뢰할 수 있는 성과 지표를 산출할 수 없는 경우에 해당합니다.

업데이트 주기: 일별

최고 수익율의 내부자 목록을 확인하세요.

가장 높은 순위의 내부자를 확인하세요
내부자 포지션이 보고된 기업

SEC 서류에 따르면 OrbiMed Capital GP III LLC 기업이 다음 기업에 대한 보유 또는 거래를 보고했습니다:

증권 소유권 최근 보고된 보유 주식
US:VRAY / ViewRay Inc. 10% Owner 73,819
US:PIRS / Pieris Pharmaceuticals, Inc. 10% Owner 38,870
US:GKOS / Glaukos Corporation Director 0
US:ROKA / Roka Bioscience, Inc. 10% Owner 0
Director, 10% Owner 0
US:SELB / Selecta Biosciences Inc Director, 10% Owner 0
US:SIEN / Sientra, Inc. 10% Owner 17,100
10% Owner 14,067
US:AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Director 5,700
10% Owner 27,859
US:PCRX / Pacira BioSciences, Inc. 10% Owner 2,446,000
차트 해석 방법

아래 차트는 OrbiMed Capital GP III LLC에 의한 각 "공개 시장"(Open market)에서 계획되지 않은 거래 이후 증권의 주가 실적을 보여줍니다. 계획되지 않은 거래는 10b5-1 거래 계획의 일환으로 이루어지지 않은 거래입니다. 주가 실적은 주가의 누적 백분율 변화로 표시됩니다. 예를 들어, 2019년 1월 1일 내부자의 매매 거래가 이루어졌을 경우, 차트는 현재까지 증권의 일별 백분율 변화를 보여줍니다. 이 기간 동안 주가가 10달러에서 15달러로 간다면, 주가의 누적 백분율 변화는 50%가 됩니다. 10달러에서 20달러로의 가격 변화는 100%가 되며, 10달러에서 5달러로의 가격 변화는 -50%가 됩니다.

궁극적으로 내부자의 매매 거래가 내부자의 정보를 이용하여 이익을 얻기 위해 거래 타이밍을 맞추고 있는지 확인하기 위해 내부자의 매매 거래가 주가의 초과 수익률(양 또는 음)과 얼마나 밀접한 상관 관계가 있는지 확인하고자 합니다. 내부자가 이러한 작업을 수행하고 있는 상황을 고려해 보겠습니다. 이러한 상황에서 우리는 (a) 매입 후 양의 수익률 또는 (b) 매각 후 음의 수익률을 기대할 수 있습니다. (a)의 경우, 매입 차트는 상향으로 기울어진 일련의 곡선을 보여주며, 각 매입 거래 후 양의 수익률을 나타냅니다. (b)의 경우, SALE 차트는 하향으로 기울어진 일련의 곡선을 보여주며, 각 판매 거래 후 음의 수익률을 나타냅니다.

그러나 이것만으로는 결론을 도출하기에 충분하지 않습니다. 예를 들어, 해당 기업의 주가가 수년에 걸쳐 비주기적 상승 추세에 있다면, Fintel은 매입 후 도표가 모두 상향 곡선으로 예상할 수 있습니다. 마찬가지로, 수년에 걸쳐 비주기적 하락은 거래 후에 하향 곡선으로 초래할 가능성이 높습니다. 이 도표들 중 어느 것도 내부자의 매매 거래 활동을 시사하지는 않습니다.

가장 강력한 지표는 주가가 극단적으로 순환하는 상황일 것이고, PURCHASE 차트에는 긍정적인 시그널이, SALE 차트에는 부정적인 플롯이 존재했습니다. 이는 자신들의 금전적 이익을 위한 거래 타이밍을 재던 내부자에 의한 상황일 가능성이 높습니다.

내부자 매입 AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock): 단기 이익 분석

이 섹션에서는 AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)에 대한 "공개 시장"(Open market)에서 계획되지 않은 내부자의 매입이 발생한 모든 상품의 수익성을 분석합니다. 이 분석은 내부자가 지속적으로 비정상적인 수익을 창출하는지 이해하는 데 도움이 되며, 이를 따를 가치가 있습니다. 이 분석은 각 거래 후 1년 동안 수행되며, 결과는 이론 값입니다.

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장 매입을 보여줍니다.

거래일 티커 내부자 보고된
지분		 보고된
가격		 조정된
지분		 조정된
가격		 가격 기준 최고까지
일수		 최고
가격		 최고
이익 ($)		 최고 수익률 (%)
이 내부자와 유가 증권의 조합과 관련하여 계획되지 않은 공개된 "공개 시장"(Open market) 거래는 없습니다.

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Insider Trades
내부자 매매 AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock): 단기 손실 분석

이 섹션에서는 AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)에서 이루어진 계획되지 않은 모든 공개 시장에서의 내부자 매도의 단기 손실 회피를 분석합니다. 일관된 손실 회피 패턴은 향후 매각 거래에서 가격 하락이 발생할 수도 있다는 것을 예측할 수 있습니다. 이 분석은 각 거래 후 1년을 대상으로 한 것이며, 결과는 이론 값입니다.

아래 표는 자동 거래 계획에 포함되지 않은 가장 최근의 "공개 시장"(Open market) 매매를 보여줍니다.

거래일 티커 내부자 보고된
지분		 보고된
가격		 조정된
지분		 조정된
가격		 가격 기준 최저까지
일수		 최저에서
가격		 회피된
최대 손실($)		 회피된
최대 손실율(%)
2012-06-19 AMRN ORBIMED ADVISORS LLC 611,200 12.9127 30,560 258.2540 7,892,242 310 6.39 -7,696,964 -97.53
2012-06-19 AMRN ORBIMED ADVISORS LLC 5,900 12.9127 295 258.2540 76,185

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Insider Trades
내부자 매입 GKOS / Glaukos Corporation: 단기 이익 분석

이 섹션에서는 AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)에 대한 "공개 시장"(Open market)에서 계획되지 않은 내부자의 매입이 발생한 모든 상품의 수익성을 분석합니다. 이 분석은 내부자가 지속적으로 비정상적인 수익을 창출하는지 이해하는 데 도움이 되며, 이를 따를 가치가 있습니다. 이 분석은 각 거래 후 1년 동안 수행되며, 결과는 이론 값입니다.

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장 매입을 보여줍니다.

거래일 티커 내부자 보고된
지분		 보고된
가격		 조정된
지분		 조정된
가격		 가격 기준 최고까지
일수		 최고
가격		 최고
이익 ($)		 최고 수익률 (%)
이 내부자와 유가 증권의 조합과 관련하여 계획되지 않은 공개된 "공개 시장"(Open market) 거래는 없습니다.

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

GKOS / Glaukos Corporation Insider Trades
내부자 매매 GKOS / Glaukos Corporation: 단기 손실 분석

이 섹션에서는 AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)에서 이루어진 계획되지 않은 모든 공개 시장에서의 내부자 매도의 단기 손실 회피를 분석합니다. 일관된 손실 회피 패턴은 향후 매각 거래에서 가격 하락이 발생할 수도 있다는 것을 예측할 수 있습니다. 이 분석은 각 거래 후 1년을 대상으로 한 것이며, 결과는 이론 값입니다.

아래 표는 자동 거래 계획에 포함되지 않은 가장 최근의 "공개 시장"(Open market) 매매를 보여줍니다.

거래일 티커 내부자 보고된
지분		 보고된
가격		 조정된
지분		 조정된
가격		 가격 기준 최저까지
일수		 최저에서
가격		 회피된
최대 손실($)		 회피된
최대 손실율(%)
2018-03-06 GKOS ORBIMED ADVISORS LLC 93,008 30.0100 93,008 30.0100 2,791,170 38 27.6200 -222,289 -7.96
2018-03-06 GKOS ORBIMED ADVISORS LLC 886 30.0100 886 30.0100 26,589
2018-03-06 GKOS ORBIMED ADVISORS LLC 20,114 30.7700 20,114 30.7700 618,908
2018-03-06 GKOS ORBIMED ADVISORS LLC 192 30.7700 192 30.7700 5,908
2018-03-06 GKOS ORBIMED ADVISORS LLC 46,676 32.0600 46,676 32.0600 1,496,433
2018-03-06 GKOS ORBIMED ADVISORS LLC 445 32.0600 445 32.0600 14,267
2018-03-05 GKOS ORBIMED ADVISORS LLC 128,092 32.0500 128,092 32.0500 4,105,349
2018-03-05 GKOS ORBIMED ADVISORS LLC 1,220 32.0500 1,220 32.0500 39,101
2018-03-05 GKOS ORBIMED ADVISORS LLC 80,516 33.0600 80,516 33.0600 2,661,859
2018-03-05 GKOS ORBIMED ADVISORS LLC 768 33.0600 768 33.0600 25,390
2018-03-02 GKOS ORBIMED ADVISORS LLC 265,766 31.9200 265,766 31.9200 8,483,251
2018-03-02 GKOS ORBIMED ADVISORS LLC 2,533 31.9200 2,533 31.9200 80,853
2018-03-02 GKOS ORBIMED ADVISORS LLC 194,433 32.8000 194,433 32.8000 6,377,402
2018-03-02 GKOS ORBIMED ADVISORS LLC 1,851 32.8000 1,851 32.8000 60,713
2017-09-05 GKOS ORBIMED ADVISORS LLC 173,349 37.9400 173,349 37.9400 6,576,861
2017-09-05 GKOS ORBIMED ADVISORS LLC 1,651 37.9400 1,651 37.9400 62,639
2017-09-05 GKOS ORBIMED ADVISORS LLC 189,792 39.6300 189,792 39.6300 7,521,457
2017-09-05 GKOS ORBIMED ADVISORS LLC 1,808 39.6300 1,808 39.6300 71,651
2017-09-05 GKOS ORBIMED ADVISORS LLC 58,047 40.7700 58,047 40.7700 2,366,576
2017-09-05 GKOS ORBIMED ADVISORS LLC 553 40.7700 553 40.7700 22,546
2017-09-01 GKOS ORBIMED ADVISORS LLC 109,040 37.7200 109,040 37.7200 4,112,989
2017-09-01 GKOS ORBIMED ADVISORS LLC 1,038 37.7200 1,038 37.7200 39,153
2017-08-31 GKOS ORBIMED ADVISORS LLC 44,498 37.8200 44,498 37.8200 1,682,914
2017-08-31 GKOS ORBIMED ADVISORS LLC 424 37.8200 424 37.8200 16,036
2017-08-17 GKOS ORBIMED ADVISORS LLC 224,780 37.8500 224,780 37.8500 8,507,923
2017-08-17 GKOS ORBIMED ADVISORS LLC 2,140 37.8500 2,140 37.8500 80,999
2017-08-16 GKOS ORBIMED ADVISORS LLC 64,961 38.0100 64,961 38.0100 2,469,168
2017-08-16 GKOS ORBIMED ADVISORS LLC 619 38.0100 619 38.0100 23,528
2017-08-15 GKOS ORBIMED ADVISORS LLC 32,193 38.2900 32,193 38.2900 1,232,670
2017-08-15 GKOS ORBIMED ADVISORS LLC 307 38.2900 307 38.2900 11,755
2017-03-14 GKOS ORBIMED ADVISORS LLC 73,401 44.5400 73,401 44.5400 3,269,281
2017-03-14 GKOS ORBIMED ADVISORS LLC 699 44.5400 699 44.5400 31,133
2017-03-13 GKOS ORBIMED ADVISORS LLC 208,712 45.3000 208,712 45.3000 9,454,654
2017-03-13 GKOS ORBIMED ADVISORS LLC 1,998 45.3000 1,998 45.3000 90,509
2017-03-13 GKOS ORBIMED ADVISORS LLC 693 46.1300 693 46.1300 31,968
2017-03-13 GKOS ORBIMED ADVISORS LLC 7 46.1300 7 46.1300 323
2017-03-10 GKOS ORBIMED ADVISORS LLC 96,113 45.9800 96,113 45.9800 4,419,276
2017-03-10 GKOS ORBIMED ADVISORS LLC 915 45.9800 915 45.9800 42,072
2017-03-03 GKOS ORBIMED ADVISORS LLC 55,246 47.0500 55,246 47.0500 2,599,324
2017-03-03 GKOS ORBIMED ADVISORS LLC 526 47.0500 526 47.0500 24,748
2016-08-12 GKOS ORBIMED ADVISORS LLC 13,967 33.7200 13,967 33.7200 470,967
2016-08-12 GKOS ORBIMED ADVISORS LLC 133 33.7200 133 33.7200 4,485
2016-08-11 GKOS ORBIMED ADVISORS LLC 159,382 33.6300 159,382 33.6300 5,360,017
2016-08-11 GKOS ORBIMED ADVISORS LLC 1,518 33.6300 1,518 33.6300 51,050
2016-08-10 GKOS ORBIMED ADVISORS LLC 116,825 33.7700 116,825 33.7700 3,945,180
2016-08-10 GKOS ORBIMED ADVISORS LLC 1,113 33.7700 1,113 33.7700 37,586
2016-08-03 GKOS ORBIMED ADVISORS LLC 420,990 30.5900 420,990 30.5900 12,878,084
2016-08-03 GKOS ORBIMED ADVISORS LLC 4,010 30.5900 4,010 30.5900 122,666

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

GKOS / Glaukos Corporation Insider Trades
내부자 매입 PCRX / Pacira BioSciences, Inc.: 단기 이익 분석

이 섹션에서는 AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)에 대한 "공개 시장"(Open market)에서 계획되지 않은 내부자의 매입이 발생한 모든 상품의 수익성을 분석합니다. 이 분석은 내부자가 지속적으로 비정상적인 수익을 창출하는지 이해하는 데 도움이 되며, 이를 따를 가치가 있습니다. 이 분석은 각 거래 후 1년 동안 수행되며, 결과는 이론 값입니다.

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장 매입을 보여줍니다.

거래일 티커 내부자 보고된
지분		 보고된
가격		 조정된
지분		 조정된
가격		 가격 기준 최고까지
일수		 최고
가격		 최고
이익 ($)		 최고 수익률 (%)
이 내부자와 유가 증권의 조합과 관련하여 계획되지 않은 공개된 "공개 시장"(Open market) 거래는 없습니다.

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

PCRX / Pacira BioSciences, Inc. Insider Trades
내부자 매매 PCRX / Pacira BioSciences, Inc.: 단기 손실 분석

이 섹션에서는 AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)에서 이루어진 계획되지 않은 모든 공개 시장에서의 내부자 매도의 단기 손실 회피를 분석합니다. 일관된 손실 회피 패턴은 향후 매각 거래에서 가격 하락이 발생할 수도 있다는 것을 예측할 수 있습니다. 이 분석은 각 거래 후 1년을 대상으로 한 것이며, 결과는 이론 값입니다.

아래 표는 자동 거래 계획에 포함되지 않은 가장 최근의 "공개 시장"(Open market) 매매를 보여줍니다.

거래일 티커 내부자 보고된
지분		 보고된
가격		 조정된
지분		 조정된
가격		 가격 기준 최저까지
일수		 최저에서
가격		 회피된
최대 손실($)		 회피된
최대 손실율(%)
2012-03-12 PCRX ORBIMED ADVISORS LLC 62,400 11.0318 62,400 11.0318 688,384 31 9.73 -81,232 -11.80
2012-03-12 PCRX ORBIMED ADVISORS LLC 700 11.0318 700 11.0318 7,722
2012-03-09 PCRX ORBIMED ADVISORS LLC 36,700 11.2456 36,700 11.2456 412,714
2012-03-09 PCRX ORBIMED ADVISORS LLC 300 11.2456 300 11.2456 3,374
2012-02-29 PCRX ORBIMED ADVISORS LLC 3,000 10.8614 3,000 10.8614 32,584
2012-02-28 PCRX ORBIMED ADVISORS LLC 10,000 11.1204 10,000 11.1204 111,204
2012-02-28 PCRX ORBIMED ADVISORS LLC 100 11.1204 100 11.1204 1,112
2012-02-27 PCRX ORBIMED ADVISORS LLC 28,700 11.0472 28,700 11.0472 317,055
2012-02-27 PCRX ORBIMED ADVISORS LLC 300 11.0472 300 11.0472 3,314
2012-02-03 PCRX ORBIMED ADVISORS LLC 49,500 10.7904 49,500 10.7904 534,125
2012-02-03 PCRX ORBIMED ADVISORS LLC 500 10.7904 500 10.7904 5,395
2012-02-02 PCRX ORBIMED ADVISORS LLC 23,100 10.8548 23,100 10.8548 250,746
2012-02-02 PCRX ORBIMED ADVISORS LLC 200 10.8548 200 10.8548 2,171
2012-02-01 PCRX ORBIMED ADVISORS LLC 69,300 11.0058 69,300 11.0058 762,702
2012-02-01 PCRX ORBIMED ADVISORS LLC 700 11.0058 700 11.0058 7,704

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

PCRX / Pacira BioSciences, Inc. Insider Trades
내부자 매입 RNAC / Cartesian Therapeutics, Inc.: 단기 이익 분석

이 섹션에서는 AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)에 대한 "공개 시장"(Open market)에서 계획되지 않은 내부자의 매입이 발생한 모든 상품의 수익성을 분석합니다. 이 분석은 내부자가 지속적으로 비정상적인 수익을 창출하는지 이해하는 데 도움이 되며, 이를 따를 가치가 있습니다. 이 분석은 각 거래 후 1년 동안 수행되며, 결과는 이론 값입니다.

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장 매입을 보여줍니다.

거래일 티커 내부자 보고된
지분		 보고된
가격		 조정된
지분		 조정된
가격		 가격 기준 최고까지
일수		 최고
가격		 최고
이익 ($)		 최고 수익률 (%)
2016-06-27 SELB ORBIMED ADVISORS LLC 5,189 14.0000 5,189 14.0000 72,646 151 26.3300 63,980 88.07
2016-06-27 SELB ORBIMED ADVISORS LLC 544,811 14.0000 544,811 14.0000 7,627,354

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

RNAC / Cartesian Therapeutics, Inc. Insider Trades
내부자 매매 RNAC / Cartesian Therapeutics, Inc.: 단기 손실 분석

이 섹션에서는 AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)에서 이루어진 계획되지 않은 모든 공개 시장에서의 내부자 매도의 단기 손실 회피를 분석합니다. 일관된 손실 회피 패턴은 향후 매각 거래에서 가격 하락이 발생할 수도 있다는 것을 예측할 수 있습니다. 이 분석은 각 거래 후 1년을 대상으로 한 것이며, 결과는 이론 값입니다.

아래 표는 자동 거래 계획에 포함되지 않은 가장 최근의 "공개 시장"(Open market) 매매를 보여줍니다.

거래일 티커 내부자 보고된
지분		 보고된
가격		 조정된
지분		 조정된
가격		 가격 기준 최저까지
일수		 최저에서
가격		 회피된
최대 손실($)		 회피된
최대 손실율(%)
이 내부자와 유가 증권의 조합과 관련하여 계획되지 않은 공개된 "공개 시장"(Open market) 거래는 없습니다.

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

RNAC / Cartesian Therapeutics, Inc. Insider Trades
내부자 매입 VRAYQ / ViewRay Systems, Inc.: 단기 이익 분석

이 섹션에서는 AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)에 대한 "공개 시장"(Open market)에서 계획되지 않은 내부자의 매입이 발생한 모든 상품의 수익성을 분석합니다. 이 분석은 내부자가 지속적으로 비정상적인 수익을 창출하는지 이해하는 데 도움이 되며, 이를 따를 가치가 있습니다. 이 분석은 각 거래 후 1년 동안 수행되며, 결과는 이론 값입니다.

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장 매입을 보여줍니다.

거래일 티커 내부자 보고된
지분		 보고된
가격		 조정된
지분		 조정된
가격		 가격 기준 최고까지
일수		 최고
가격		 최고
이익 ($)		 최고 수익률 (%)
2017-01-18 VRAY ORBIMED ADVISORS LLC 327,459 3.0000 327,459 3.0000 982,377 358 10.1200 2,331,508 237.33
2017-01-18 VRAY ORBIMED ADVISORS LLC 3,118 3.0000 3,118 3.0000 9,354
2016-08-22 VRAY ORBIMED ADVISORS LLC 1,127,338 2.9500 1,127,338 2.9500 3,325,647
2016-08-22 VRAY ORBIMED ADVISORS LLC 10,736 2.9500 10,736 2.9500 31,671

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

VRAYQ / ViewRay Systems, Inc. Insider Trades
내부자 매매 VRAYQ / ViewRay Systems, Inc.: 단기 손실 분석

이 섹션에서는 AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)에서 이루어진 계획되지 않은 모든 공개 시장에서의 내부자 매도의 단기 손실 회피를 분석합니다. 일관된 손실 회피 패턴은 향후 매각 거래에서 가격 하락이 발생할 수도 있다는 것을 예측할 수 있습니다. 이 분석은 각 거래 후 1년을 대상으로 한 것이며, 결과는 이론 값입니다.

아래 표는 자동 거래 계획에 포함되지 않은 가장 최근의 "공개 시장"(Open market) 매매를 보여줍니다.

거래일 티커 내부자 보고된
지분		 보고된
가격		 조정된
지분		 조정된
가격		 가격 기준 최저까지
일수		 최저에서
가격		 회피된
최대 손실($)		 회피된
최대 손실율(%)
2018-08-20 VRAY ORBIMED ADVISORS LLC 153,921 9.9800 153,921 9.9800 1,536,132 354 3.1000 -1,058,976 -68.94
2018-08-20 VRAY ORBIMED ADVISORS LLC 1,466 9.9800 1,466 9.9800 14,631
2018-08-20 VRAY ORBIMED ADVISORS LLC 153,921 9.9800 153,921 9.9800 1,536,132
2018-08-20 VRAY ORBIMED ADVISORS LLC 153,921 9.9800 153,921 9.9800 1,536,132
2018-08-16 VRAY ORBIMED ADVISORS LLC 362,765 9.9400 362,765 9.9400 3,605,884
2018-08-16 VRAY ORBIMED ADVISORS LLC 3,455 9.9400 3,455 9.9400 34,343
2018-08-16 VRAY ORBIMED ADVISORS LLC 362,765 9.9400 362,765 9.9400 3,605,884
2018-08-16 VRAY ORBIMED ADVISORS LLC 3,455 9.9400 3,455 9.9400 34,343
2018-08-15 VRAY ORBIMED ADVISORS LLC 77,314 9.9300 77,314 9.9300 767,728
2018-08-15 VRAY ORBIMED ADVISORS LLC 736 9.9300 736 9.9300 7,308
2018-08-14 VRAY ORBIMED ADVISORS LLC 20,777 9.9400 20,777 9.9400 206,523
2018-08-14 VRAY ORBIMED ADVISORS LLC 198 9.9400 198 9.9400 1,968
2018-08-13 VRAY ORBIMED ADVISORS LLC 86,103 9.9800 86,103 9.9800 859,308
2018-08-13 VRAY ORBIMED ADVISORS LLC 820 9.9800 820 9.9800 8,184
2018-08-10 VRAY ORBIMED ADVISORS LLC 678,333 9.9600 678,333 9.9600 6,756,197
2018-08-10 VRAY ORBIMED ADVISORS LLC 6,460 9.9600 6,460 9.9600 64,342
2018-08-09 VRAY ORBIMED ADVISORS LLC 108,729 9.9500 108,729 9.9500 1,081,854
2018-08-09 VRAY ORBIMED ADVISORS LLC 1,036 9.9500 1,036 9.9500 10,308
2018-08-09 VRAY ORBIMED ADVISORS LLC 64,575 9.9100 64,575 9.9100 639,938
2018-08-09 VRAY ORBIMED ADVISORS LLC 615 9.9100 615 9.9100 6,095
2018-08-09 VRAY ORBIMED ADVISORS LLC 26,139 9.8600 26,139 9.8600 257,731
2018-08-09 VRAY ORBIMED ADVISORS LLC 249 9.8600 249 9.8600 2,455
2018-08-08 VRAY ORBIMED ADVISORS LLC 478,107 10.0000 478,107 10.0000 4,781,070
2018-08-08 VRAY ORBIMED ADVISORS LLC 4,553 10.0000 4,553 10.0000 45,530
2018-08-07 VRAY ORBIMED ADVISORS LLC 50,149 10.0100 50,149 10.0100 501,991
2018-08-07 VRAY ORBIMED ADVISORS LLC 478 10.0100 478 10.0100 4,785
2018-08-03 VRAY ORBIMED ADVISORS LLC 118,168 11.7100 118,168 11.7100 1,383,747
2018-08-03 VRAY ORBIMED ADVISORS LLC 1,125 11.7100 1,125 11.7100 13,174

조정 가격은 분할 조정된 가격입니다. 조정된 주식은 조정된 지분입니다.

VRAYQ / ViewRay Systems, Inc. Insider Trades
내부자의 매매 거래 내역

아래 표는 증권거래위원회(SEC)에 공시된 OrbiMed Capital GP III LLC의 내부자의 전체 거래 목록입니다.

보고일 거래일 보고 티커 증권 코드 10b5-1 지분 잔여 지분 변동률
(%)		 지분
가치		 거래
가치		 잔여
가치
2018-08-21 2018-08-15 4/A VRAY ViewRay, Inc.
Common Stock 		S - Sale -736 73,819 -0.99 9.93 -7,308 733,023
2018-08-21 2018-08-15 4/A VRAY ViewRay, Inc.
Common Stock 		S - Sale -77,314 7,751,662 -0.99 9.93 -767,728 76,974,004
2018-08-21 2018-08-14 4/A VRAY ViewRay, Inc.
Common Stock 		S - Sale -198 74,555 -0.26 9.94 -1,968 741,077
2018-08-21 2018-08-14 4/A VRAY ViewRay, Inc.
Common Stock 		S - Sale -20,777 7,828,976 -0.26 9.94 -206,523 77,820,021
2018-08-21 2018-08-13 4/A VRAY ViewRay, Inc.
Common Stock 		S - Sale -820 74,753 -1.09 9.98 -8,184 746,035
2018-08-21 2018-08-13 4/A VRAY ViewRay, Inc.
Common Stock 		S - Sale -86,103 7,849,753 -1.08 9.98 -859,308 78,340,535
2018-08-21 2018-08-20 4/A VRAY ViewRay, Inc.
Common Stock 		S - Sale -153,921 68,898 -69.08 9.98 -1,536,132 687,602
2018-08-21 2018-08-20 4/A VRAY ViewRay, Inc.
Common Stock 		S - Sale -153,921 7,234,976 -2.08 9.98 -1,536,132 72,205,060
2018-08-21 2018-08-16 4/A VRAY ViewRay, Inc.
Common Stock 		S - Sale -3,455 70,364 -4.68 9.94 -34,343 699,418
2018-08-21 2018-08-16 4/A VRAY ViewRay, Inc.
Common Stock 		S - Sale -362,765 7,388,897 -4.68 9.94 -3,605,884 73,445,636
2018-08-20 2018-08-20 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -1,466 69,617 -2.06 9.98 -14,631 694,778
2018-08-20 2018-08-20 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -153,921 7,310,457 -2.06 9.98 -1,536,132 72,958,361
2018-08-20 2018-08-16 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -3,455 71,083 -4.64 9.94 -34,343 706,565
2018-08-20 2018-08-16 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -362,765 7,464,378 -4.63 9.94 -3,605,884 74,195,917
2018-08-15 2018-08-15 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -736 74,538 -0.98 9.93 -7,308 740,162
2018-08-15 2018-08-15 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -77,314 7,827,143 -0.98 9.93 -767,728 77,723,530
2018-08-15 2018-08-14 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -198 75,274 -0.26 9.94 -1,968 748,224
2018-08-15 2018-08-14 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -20,777 7,904,457 -0.26 9.94 -206,523 78,570,303
2018-08-15 2018-08-13 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -820 75,472 -1.07 9.98 -8,184 753,211
2018-08-15 2018-08-13 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -86,103 7,925,234 -1.07 9.98 -859,308 79,093,835
2018-08-10 2018-08-10 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -6,460 75,573 -7.87 9.96 -64,342 752,707
2018-08-10 2018-08-10 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -678,333 7,935,856 -7.87 9.96 -6,756,197 79,041,126
2018-08-10 2018-08-09 4 VRAY ViewRay, Inc.
Stock Option (right to buy) 		M - Exercise -431 0 -100.00
2018-08-10 2018-08-09 4 VRAY ViewRay, Inc.
Stock Option (right to buy) 		M - Exercise -45,203 0 -100.00
2018-08-10 2018-08-09 4 VRAY ViewRay, Inc.
Stock Option (right to buy) 		M - Exercise -184 0 -100.00
2018-08-10 2018-08-09 4 VRAY ViewRay, Inc.
Stock Option (right to buy) 		M - Exercise -19,372 0 -100.00
2018-08-10 2018-08-09 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -249 82,033 -0.30 9.86 -2,455 808,845
2018-08-10 2018-08-09 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -26,139 8,614,189 -0.30 9.86 -257,731 84,935,904
2018-08-10 2018-08-09 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -615 82,282 -0.74 9.91 -6,095 815,415
2018-08-10 2018-08-09 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -64,575 8,640,328 -0.74 9.91 -639,938 85,625,650
2018-08-10 2018-08-09 4 VRAY ViewRay, Inc.
Common Stock 		M - Exercise 431 82,897 0.52 5.00 2,155 414,485
2018-08-10 2018-08-09 4 VRAY ViewRay, Inc.
Common Stock 		M - Exercise 45,203 8,704,903 0.52 5.00 226,015 43,524,515
2018-08-10 2018-08-09 4 VRAY ViewRay, Inc.
Common Stock 		M - Exercise 184 82,466 0.22 5.00 920 412,330
2018-08-10 2018-08-09 4 VRAY ViewRay, Inc.
Common Stock 		M - Exercise 19,372 8,659,700 0.22 5.00 96,860 43,298,500
2018-08-10 2018-08-09 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -1,036 82,282 -1.24 9.95 -10,308 818,706
2018-08-10 2018-08-09 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -108,729 8,640,328 -1.24 9.95 -1,081,854 85,971,264
2018-08-10 2018-08-08 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -4,553 83,318 -5.18 10.00 -45,530 833,180
2018-08-10 2018-08-08 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -478,107 8,749,057 -5.18 10.00 -4,781,070 87,490,570
2018-08-10 2018-08-07 4 VRAY ViewRay, Inc.
Restricted Stock Unit 		M - Exercise -249 0 -100.00
2018-08-10 2018-08-07 4 VRAY ViewRay, Inc.
Restricted Stock Unit 		M - Exercise -26,139 0 -100.00
2018-08-10 2018-08-07 4 VRAY ViewRay, Inc.
Common Stock 		M - Exercise 249 87,871 0.28
2018-08-10 2018-08-07 4 VRAY ViewRay, Inc.
Common Stock 		M - Exercise 26,139 9,227,164 0.28
2018-08-07 2018-08-07 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -478 87,622 -0.54 10.01 -4,785 877,096
2018-08-07 2018-08-07 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -50,149 9,201,025 -0.54 10.01 -501,991 92,102,260
2018-08-07 2018-08-03 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -1,125 88,100 -1.26 11.71 -13,174 1,031,651
2018-08-07 2018-08-03 4 VRAY ViewRay, Inc.
Common Stock 		S - Sale -118,168 9,251,174 -1.26 11.71 -1,383,747 108,331,248
2018-05-02 2018-04-30 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		S - Sale -10,400 38,870 -21.11 6.35 -66,040 246,824
2018-05-02 2018-04-30 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		S - Sale -989,600 4,511,130 -17.99 6.35 -6,283,960 28,645,676
2018-03-06 2018-03-06 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -445 0 -100.00 32.06 -14,267
2018-03-06 2018-03-06 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -46,676 0 -100.00 32.06 -1,496,433
2018-03-06 2018-03-06 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -192 445 -30.14 30.77 -5,908 13,693
2018-03-06 2018-03-06 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -20,114 46,676 -30.12 30.77 -618,908 1,436,221
2018-03-06 2018-03-06 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -886 637 -58.17 30.01 -26,589 19,116
2018-03-06 2018-03-06 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -93,008 66,790 -58.20 30.01 -2,791,170 2,004,368
2018-03-06 2018-03-05 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -768 1,523 -33.52 33.06 -25,390 50,350
2018-03-06 2018-03-05 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -80,516 159,798 -33.50 33.06 -2,661,859 5,282,922
2018-03-06 2018-03-05 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -1,220 2,291 -34.75 32.05 -39,101 73,427
2018-03-06 2018-03-05 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -128,092 240,314 -34.77 32.05 -4,105,349 7,702,064
2018-03-06 2018-03-02 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -1,851 3,511 -34.52 32.80 -60,713 115,161
2018-03-06 2018-03-02 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -194,433 368,406 -34.55 32.80 -6,377,402 12,083,717
2018-03-06 2018-03-02 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -2,533 5,362 -32.08 31.92 -80,853 171,155
2018-03-06 2018-03-02 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -265,766 562,839 -32.07 31.92 -8,483,251 17,965,821
2018-02-15 2018-02-13 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -17 0 -100.00
2018-02-15 2018-02-13 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -1,765 0 -100.00
2018-02-15 2018-02-13 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -58 0 -100.00
2018-02-15 2018-02-13 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -6,057 0 -100.00
2018-02-15 2018-02-13 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		S - Sale -75 49,270 -0.15 8.98 -674 442,445
2018-02-15 2018-02-13 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		S - Sale -7,822 5,500,730 -0.14 8.98 -70,242 49,396,555
2018-02-15 2018-02-13 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 17 49,345 0.03 5.08 86 250,673
2018-02-15 2018-02-13 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 1,765 5,508,552 0.03 5.08 8,966 27,983,444
2018-02-15 2018-02-13 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 58 49,328 0.12 4.68 271 230,855
2018-02-15 2018-02-13 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 6,057 5,506,787 0.11 4.68 28,347 25,771,763
2018-01-04 2018-01-03 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		S - Sale -16,128 49,270 -24.66 7.35 -118,541 362,134
2018-01-04 2018-01-03 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		S - Sale -1,693,492 5,500,730 -23.54 7.35 -12,447,166 40,430,366
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -47 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -4,971 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -99 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -10,447 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -97 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -97 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -10,216 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -142 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -14,858 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -97 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -10,182 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -92 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -9,642 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -77 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -8,097 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -189 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -19,811 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -10,180 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -83 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -8,717 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -63 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -6,654 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -50 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -5,227 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -259 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) 		M - Exercise -27,241 0 -100.00
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		S - Sale -1,392 65,398 -2.08 5.70 -7,934 372,769
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		S - Sale -146,243 7,194,222 -1.99 5.70 -833,585 41,007,065
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 47 66,790 0.07 5.64 265 376,696
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 4,971 7,340,465 0.07 5.64 28,036 41,400,223
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 99 66,743 0.15 2.32 230 154,844
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10,447 7,335,494 0.14 2.32 24,237 17,018,346
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 97 66,644 0.15 2.01 195 133,954
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10,216 7,325,047 0.14 2.01 20,534 14,723,344
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 142 66,547 0.21 2.01 285 133,759
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 14,858 7,314,831 0.20 2.01 29,865 14,702,810
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 97 66,405 0.15 1.64 159 108,904
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10,182 7,299,973 0.14 1.64 16,698 11,971,956
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 92 66,308 0.14 1.73 159 114,713
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 9,642 7,289,791 0.13 1.73 16,681 12,611,338
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 77 66,216 0.12 2.05 158 135,743
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 8,097 7,280,149 0.11 2.05 16,599 14,924,305
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 189 66,139 0.29 1.59 301 105,161
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 19,811 7,272,052 0.27 1.59 31,499 11,562,563
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 97 65,950 0.15 1.62 157 106,839
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10,180 7,252,241 0.14 1.62 16,492 11,748,630
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 83 65,853 0.13 1.94 161 127,755
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 8,717 7,242,061 0.12 1.94 16,911 14,049,598
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 63 65,770 0.10 2.62 165 172,317
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 6,654 7,233,344 0.09 2.62 17,433 18,951,361
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 50 65,707 0.08 3.00 150 197,121
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 5,227 7,226,690 0.07 3.00 15,681 21,680,070
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 259 65,657 0.40 2.00 518 131,314
2017-12-20 2017-12-18 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 27,241 7,221,463 0.38 2.00 54,482 14,442,926
2017-10-05 2017-10-03 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -1,899 0 -100.00 0.68 -1,291
2017-10-05 2017-10-03 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -199,718 0 -100.00 0.68 -135,808
2017-10-02 2017-09-29 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -888 1,899 -31.86 0.74 -657 1,405
2017-10-02 2017-09-29 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -93,246 199,718 -31.83 0.74 -69,002 147,791
2017-10-02 2017-09-28 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -3,592 2,787 -56.31 0.72 -2,586 2,007
2017-10-02 2017-09-28 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -376,950 292,964 -56.27 0.72 -271,404 210,934
2017-09-28 2017-09-27 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -498 6,379 -7.24 0.92 -458 5,869
2017-09-28 2017-09-27 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -52,301 669,914 -7.24 0.92 -48,117 616,321
2017-09-28 2017-09-26 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -706 6,877 -9.31 1.03 -727 7,083
2017-09-28 2017-09-26 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -74,096 722,215 -9.30 1.03 -76,319 743,881
2017-09-05 2017-09-05 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -553 7,895 -6.55 40.77 -22,546 321,879
2017-09-05 2017-09-05 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -58,047 828,605 -6.55 40.77 -2,366,576 33,782,226
2017-09-05 2017-09-05 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -1,808 8,448 -17.63 39.63 -71,651 334,794
2017-09-05 2017-09-05 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -189,792 886,652 -17.63 39.63 -7,521,457 35,138,019
2017-09-05 2017-09-05 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -1,651 10,256 -13.87 37.94 -62,639 389,113
2017-09-05 2017-09-05 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -173,349 1,076,444 -13.87 37.94 -6,576,861 40,840,285
2017-09-05 2017-09-01 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -1,038 11,907 -8.02 37.72 -39,153 449,132
2017-09-05 2017-09-01 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -109,040 1,249,793 -8.02 37.72 -4,112,989 47,142,192
2017-09-05 2017-08-31 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -424 12,945 -3.17 37.82 -16,036 489,580
2017-09-05 2017-08-31 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -44,498 1,358,833 -3.17 37.82 -1,682,914 51,391,064
2017-08-25 2017-08-24 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -125 7,583 -1.62 1.50 -188 11,374
2017-08-25 2017-08-24 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -13,075 796,311 -1.62 1.50 -19,612 1,194,466
2017-08-25 2017-08-23 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -10 7,708 -0.13 1.50 -15 11,562
2017-08-25 2017-08-23 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -1,090 809,386 -0.13 1.50 -1,635 1,214,079
2017-08-22 2017-08-22 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -52 7,718 -0.67 1.52 -79 11,731
2017-08-22 2017-08-22 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -5,448 810,476 -0.67 1.52 -8,281 1,231,924
2017-08-22 2017-08-21 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -28 7,770 -0.36 1.49 -42 11,577
2017-08-22 2017-08-21 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -2,952 815,924 -0.36 1.49 -4,398 1,215,727
2017-08-22 2017-08-18 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -630 7,798 -7.48 1.52 -958 11,853
2017-08-22 2017-08-18 4 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		S - Sale -66,166 818,876 -7.48 1.52 -100,572 1,244,692
2017-08-17 2017-08-17 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -2,140 13,369 -13.80 37.85 -80,999 506,017
2017-08-17 2017-08-17 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -224,780 1,403,331 -13.81 37.85 -8,507,923 53,116,078
2017-08-17 2017-08-16 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -619 15,509 -3.84 38.01 -23,528 589,497
2017-08-17 2017-08-16 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -64,961 1,628,111 -3.84 38.01 -2,469,168 61,884,499
2017-08-17 2017-08-15 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -307 16,128 -1.87 38.29 -11,755 617,541
2017-08-17 2017-08-15 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -32,193 1,693,072 -1.87 38.29 -1,232,670 64,827,727
2017-03-14 2017-03-14 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -699 16,435 -4.08 44.54 -31,133 732,015
2017-03-14 2017-03-14 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -73,401 1,725,265 -4.08 44.54 -3,269,281 76,843,303
2017-03-14 2017-03-13 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -7 17,134 -0.04 46.13 -323 790,391
2017-03-14 2017-03-13 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -693 1,798,666 -0.04 46.13 -31,968 82,972,463
2017-03-14 2017-03-13 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -1,998 17,141 -10.44 45.30 -90,509 776,487
2017-03-14 2017-03-13 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -208,712 1,799,359 -10.39 45.30 -9,454,654 81,510,963
2017-03-14 2017-03-10 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -915 19,129 -4.56 45.98 -42,072 879,551
2017-03-14 2017-03-10 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -96,113 2,008,071 -4.57 45.98 -4,419,276 92,331,105
2017-03-07 2017-03-03 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -526 20,044 -2.56 47.05 -24,748 943,070
2017-03-07 2017-03-03 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -55,246 2,104,184 -2.56 47.05 -2,599,324 99,001,857
2017-01-20 2017-01-18 4 VRAY ViewRay, Inc.
Warrants to purchase common stock 		P - Purchase 623 3,843 19.35 0.12 78 480
2017-01-20 2017-01-18 4 VRAY ViewRay, Inc.
Warrants to purchase common stock 		P - Purchase 65,491 403,692 19.36 0.12 8,186 50,462
2017-01-20 2017-01-18 4 VRAY ViewRay, Inc.
Common Stock, par value $0.01 per share 		P - Purchase 3,118 89,225 3.62 3.00 9,354 267,675
2017-01-20 2017-01-18 4 VRAY ViewRay, Inc.
Common Stock, par value $0.01 per share 		P - Purchase 327,459 9,369,342 3.62 3.00 982,377 28,108,026
2016-12-01 2016-11-29 4 RBM RESPONSE BIOMEDICAL CORP
Common Stock 		J - Other -2,149,902 0 -100.00
2016-12-01 2016-11-29 4 RBM RESPONSE BIOMEDICAL CORP
Common Stock 		J - Other -34,291 0 -100.00
2016-12-01 2016-11-29 4 RBM RESPONSE BIOMEDICAL CORP
Common Stock 		J - Other -3,604,266 0 -100.00
2016-09-23 2016-09-21 4 ROKA Roka BioScience, Inc.
Warrants 		P - Purchase 53,909 53,909
2016-09-23 2016-09-21 4 ROKA Roka BioScience, Inc.
Warrants 		P - Purchase 5,660,377 5,660,377
2016-09-23 2016-09-21 4 ROKA Roka BioScience, Inc.
Series A Convertible Preferred Stock 		P - Purchase 38 38
2016-09-23 2016-09-21 4 ROKA Roka BioScience, Inc.
Series A Convertible Preferred Stock 		P - Purchase 3,962 3,962
2016-08-24 2016-08-22 4 VRAY ViewRay, Inc.
Warrants to purchase common stock 		P - Purchase 3,220 3,220 0.12 402 402
2016-08-24 2016-08-22 4 VRAY ViewRay, Inc.
Warrants to purchase common stock 		P - Purchase 338,201 338,201 0.12 42,275 42,275
2016-08-24 2016-08-22 4 VRAY ViewRay, Inc.
Common Stock, par value $0.01 per share 		P - Purchase 10,736 86,107 14.24 2.95 31,671 254,016
2016-08-24 2016-08-22 4 VRAY ViewRay, Inc.
Common Stock, par value $0.01 per share 		P - Purchase 1,127,338 9,041,883 14.24 2.95 3,325,647 26,673,555
2016-08-12 2016-08-12 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -133 20,570 -0.64 33.72 -4,485 693,620
2016-08-12 2016-08-12 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -13,967 2,159,430 -0.64 33.72 -470,967 72,815,980
2016-08-12 2016-08-11 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -1,518 20,703 -6.83 33.63 -51,050 696,242
2016-08-12 2016-08-11 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -159,382 2,173,397 -6.83 33.63 -5,360,017 73,091,341
2016-08-12 2016-08-10 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -1,113 22,221 -4.77 33.77 -37,586 750,403
2016-08-12 2016-08-10 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -116,825 2,332,779 -4.77 33.77 -3,945,180 78,777,947
2016-08-05 2016-08-03 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -4,010 23,334 -14.67 30.59 -122,666 713,787
2016-08-05 2016-08-03 4 GKOS GLAUKOS Corp
Common Stock, par value $0.01 per share 		S - Sale -420,990 2,449,604 -14.67 30.59 -12,878,084 74,933,386
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series E Convertible Preferred Stock 		C - Conversion -456,870 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series E Convertible Preferred Stock 		C - Conversion -4,351 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series D Convertible Preferred Stock 		C - Conversion -77,697 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series D Convertible Preferred Stock 		C - Conversion -739 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series C Convertible Preferred Stock 		C - Conversion -380,986 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series C Convertible Preferred Stock 		C - Conversion -3,628 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 544,811 1,825,415 42.54 14.00 7,627,354 25,555,810
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 5,189 17,382 42.56 14.00 72,646 243,348
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		C - Conversion 1,166,884 1,280,604 1,026.10
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		C - Conversion 11,111 12,193 1,026.89
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series E Convertible Preferred Stock 		C - Conversion -456,870 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series E Convertible Preferred Stock 		C - Conversion -4,351 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series D Convertible Preferred Stock 		C - Conversion -77,697 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series D Convertible Preferred Stock 		C - Conversion -739 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series C Convertible Preferred Stock 		C - Conversion -380,986 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Series C Convertible Preferred Stock 		C - Conversion -3,628 0 -100.00
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 544,811 1,825,415 42.54 14.00 7,627,354 25,555,810
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		P - Purchase 5,189 17,382 42.56 14.00 72,646 243,348
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		C - Conversion 1,166,884 1,280,604 1,026.10
2016-06-29 2016-06-27 4 SELB SELECTA BIOSCIENCES INC
Common Stock 		C - Conversion 11,111 12,193 1,026.89
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		115,884
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		228,522
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		115,884
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		228,522
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		115,884
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		228,522
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		115,884
2016-06-21 3 SELB SELECTA BIOSCIENCES INC
Common Stock 		228,522
2016-06-20 2016-06-16 4 RBM RESPONSE BIOMEDICAL CORP
Common Stock 		P - Purchase 331,225 2,149,902 18.21 0.56 185,486 1,203,945
2016-06-20 2016-06-16 4 RBM RESPONSE BIOMEDICAL CORP
Common Stock 		P - Purchase 5,294 34,291 18.26 0.56 2,965 19,203
2016-06-20 2016-06-16 4 RBM RESPONSE BIOMEDICAL CORP
Common Stock 		P - Purchase 556,339 3,604,266 18.25 0.56 311,550 2,018,389
2016-03-30 3 VRAY ViewRay, Inc.
Common Stock 		15,904,461
2016-03-30 3 VRAY ViewRay, Inc.
Common Stock 		8,065,287
2016-03-30 3 VRAY ViewRay, Inc.
Common Stock 		15,904,461
2016-03-30 3 VRAY ViewRay, Inc.
Common Stock 		8,065,287
2016-03-30 3 VRAY ViewRay, Inc.
Common Stock 		15,904,461
2016-03-30 3 VRAY ViewRay, Inc.
Common Stock 		8,065,287
2016-03-30 3 VRAY ViewRay, Inc.
Common Stock 		15,904,461
2016-03-30 3 VRAY ViewRay, Inc.
Common Stock 		8,065,287
2015-10-13 2015-10-12 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -2,785 17,100 -14.01 5.98 -16,654 102,258
2015-10-13 2015-10-12 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -285,106 1,767,902 -13.89 5.98 -1,704,934 10,572,054
2015-10-09 2015-10-09 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -2,041 19,885 -9.31 7.03 -14,348 139,792
2015-10-09 2015-10-09 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -210,668 2,053,008 -9.31 7.03 -1,480,996 14,432,646
2015-10-09 2015-10-08 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -3,837 21,926 -14.89 7.24 -27,780 158,744
2015-10-09 2015-10-08 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -396,163 2,263,676 -14.89 7.24 -2,868,220 16,389,014
2015-10-09 2015-10-07 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -454 25,763 -1.73 7.36 -3,341 189,616
2015-10-09 2015-10-07 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -53,446 2,659,839 -1.97 7.36 -393,363 19,576,415
2015-10-06 2015-10-06 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -59 26,217 -0.22 7.80 -460 204,493
2015-10-06 2015-10-06 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -6,941 2,713,285 -0.26 7.80 -54,140 21,163,623
2015-10-06 2015-10-05 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -1,163 26,276 -4.24 8.19 -9,525 215,200
2015-10-06 2015-10-05 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -136,937 2,720,226 -4.79 8.19 -1,121,514 22,278,651
2015-10-06 2015-10-02 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -403 27,439 -1.45 10.34 -4,167 283,719
2015-10-06 2015-10-02 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -47,497 2,857,163 -1.64 10.34 -491,119 29,543,065
2015-10-01 2015-10-01 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -400 27,842 -1.42 10.34 -4,136 287,886
2015-10-01 2015-10-01 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -47,100 2,904,660 -1.60 10.34 -487,014 30,034,184
2015-10-01 2015-09-30 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -369 28,242 -1.29 10.17 -3,753 287,221
2015-10-01 2015-09-30 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -43,471 2,951,760 -1.45 10.17 -442,100 30,019,399
2015-10-01 2015-09-29 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -89 28,611 -0.31 10.08 -897 288,399
2015-10-01 2015-09-29 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -10,469 2,995,231 -0.35 10.08 -105,528 30,191,928
2015-09-28 2015-09-28 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -89 28,700 -0.31 10.30 -917 295,610
2015-09-28 2015-09-28 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -10,513 3,005,700 -0.35 10.30 -108,284 30,958,710
2015-09-28 2015-09-25 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -311 28,789 -1.07 11.07 -3,443 318,694
2015-09-28 2015-09-25 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -66,489 3,016,213 -2.16 11.07 -736,033 33,389,478
2015-09-28 2015-09-25 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -800 29,100 -2.68 10.07 -8,056 293,037
2015-09-28 2015-09-25 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -64,400 3,082,702 -2.05 10.07 -648,508 31,042,809
2015-09-28 2015-09-24 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -8,152 3,147,102 -0.26 11.00 -89,672 34,618,122
2015-09-28 2015-09-24 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -148 29,900 -0.49 11.00 -1,628 328,900
2015-09-28 2015-09-24 4 SIEN Sientra, Inc.
Common Stock, par value $0.01 per share 		S - Sale -6 3,155,254 0.00 9.78 -59 30,858,384
2015-07-08 2015-07-06 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 4,717 65,398 7.77 2.75 12,972 179,844
2015-07-08 2015-07-06 4 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 495,283 7,194,222 7.39 2.75 1,362,028 19,784,110
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock Warrant (right to buy) 		M - Exercise -261 0 -100.00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock Warrant (right to buy) 		M - Exercise -27,346 0 -100.00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series F Convertible Preferred Stock 		C - Conversion -2,672 0 -100.00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series F Convertible Preferred Stock 		C - Conversion -280,531 0 -100.00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series E Convertible Preferred Stock 		C - Conversion -1,599 0 -100.00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series E Convertible Preferred Stock 		C - Conversion -167,898 0 -100.00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock 		C - Conversion -22,923 0 -100.00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock 		C - Conversion -2,406,441 0 -100.00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock 		F - Taxes -111 27,344 -0.40 18.00 -1,998 492,192
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock 		M - Exercise 261 27,455 0.96
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock 		F - Taxes -11,623 2,870,593 -0.40 18.00 -209,214 51,670,674
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock 		M - Exercise 27,346 2,882,216 0.96
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock 		C - Conversion 27,194 27,194
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock 		C - Conversion 2,854,870 2,854,870
2015-06-29 3 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		13,458,559
2015-06-29 3 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		6,820,301
2015-06-29 3 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		13,458,559
2015-06-29 3 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		6,820,301
2015-06-29 3 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		13,458,559
2015-06-29 3 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		6,820,301
2015-06-29 3 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		13,458,559
2015-06-29 3 PIRS PIERIS PHARMACEUTICALS, INC.
Common Stock 		6,820,301
2014-10-28 3 SIEN Sientra, Inc.
Common Stock 		6,340,568
2014-10-28 3 SIEN Sientra, Inc.
Common Stock 		3,215,356
2014-10-28 3 SIEN Sientra, Inc.
Common Stock 		6,340,568
2014-10-28 3 SIEN Sientra, Inc.
Common Stock 		3,215,356
2014-10-28 3 SIEN Sientra, Inc.
Common Stock 		6,340,568
2014-10-28 3 SIEN Sientra, Inc.
Common Stock 		3,215,356
2014-10-28 3 SIEN Sientra, Inc.
Common Stock 		6,340,568
2014-10-28 3 SIEN Sientra, Inc.
Common Stock 		3,215,356
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Series E Convertible Preferred Stock 		C - Conversion -56,490 0 -100.00
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Series E Convertible Preferred Stock 		C - Conversion -5,931,402 0 -100.00
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Series D Convertible Preferred Stock 		C - Conversion -80,715 0 -100.00
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Series D Convertible Preferred Stock 		C - Conversion -8,475,069 0 -100.00
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Series C Convertible Preferred Stock 		C - Conversion -38,021 0 -100.00
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Series C Convertible Preferred Stock 		C - Conversion -3,992,203 0 -100.00
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Series B Convertible Preferred Stock 		C - Conversion -116,981 0 -100.00
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Series B Convertible Preferred Stock 		C - Conversion -12,238,019 0 -100.00
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock, $0.001 par value per share 		P - Purchase 3,616 30,378 13.51 12.00 43,392 364,536
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock, $0.001 par value per share 		P - Purchase 379,717 3,190,051 13.51 12.00 4,556,604 38,280,612
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock, $0.001 par value per share 		C - Conversion 5,116 26,762 23.63
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock, $0.001 par value per share 		C - Conversion 537,264 2,810,334 23.64
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock, $0.001 par value per share 		C - Conversion 7,563 21,646 53.70
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock, $0.001 par value per share 		C - Conversion 794,178 2,273,070 53.70
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock, $0.001 par value per share 		C - Conversion 3,443 14,083 32.36
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock, $0.001 par value per share 		C - Conversion 361,612 1,478,892 32.37
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock, $0.001 par value per share 		C - Conversion 10,596 10,640 24,081.82
2014-07-24 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock, $0.001 par value per share 		C - Conversion 1,112,592 1,117,280 23,732.76
2014-07-16 3 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		9,420
2014-07-16 3 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		4,776
2014-07-16 3 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		9,420
2014-07-16 3 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		4,776
2014-07-16 3 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		9,420
2014-07-16 3 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		4,776
2014-07-16 3 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		9,420
2014-07-16 3 ROKA Roka BioScience, Inc.
Common Stock, par value $0.001 per share 		4,776
2013-11-12 2013-11-07 4 RBM RESPONSE BIOMEDICAL CORP
Warrant 		P - Purchase 151,632 151,632
2013-11-12 2013-11-07 4 RBM RESPONSE BIOMEDICAL CORP
Warrant 		P - Purchase 2,408 2,408
2013-11-12 2013-11-07 4 RBM RESPONSE BIOMEDICAL CORP
Warrant 		P - Purchase 254,122 254,122
2013-11-12 2013-11-07 4 RBM RESPONSE BIOMEDICAL CORP
Common Stock 		P - Purchase 303,265 1,818,677 20.01 2.45 742,999 4,455,759
2013-11-12 2013-11-07 4 RBM RESPONSE BIOMEDICAL CORP
Common Stock 		P - Purchase 4,816 28,997 19.92 2.45 11,799 71,043
2013-11-12 2013-11-07 4 RBM RESPONSE BIOMEDICAL CORP
Common Stock 		P - Purchase 508,244 3,047,927 20.01 2.45 1,245,198 7,467,421
2013-05-24 2013-05-23 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		P - Purchase 120 14,067 0.86 6.99 839 98,318
2013-05-24 2013-05-23 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		P - Purchase 12,380 1,476,702 0.85 6.99 86,528 10,321,113
2013-05-24 2013-05-22 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		P - Purchase 200 13,947 1.45 6.86 1,372 95,690
2013-05-24 2013-05-22 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		P - Purchase 21,100 1,464,322 1.46 6.86 144,767 10,046,713
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Series D Convertible Preferred Stock 		C - Conversion -18,795 0 -100.00
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Series D Convertible Preferred Stock 		C - Conversion -1,973,439 0 -100.00
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Series D-2 Convertible Preferred Stock 		C - Conversion -50,256 0 -100.00
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Series D-2 Convertible Preferred Stock 		C - Conversion -5,276,702 0 -100.00
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Series E Convertible Preferred Stock 		C - Conversion -83,959 0 -100.00
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Series E Convertible Preferred Stock 		C - Conversion -8,815,565 0 -100.00
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		P - Purchase 80 13,747 0.59 6.90 552 94,813
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		P - Purchase 8,020 1,443,222 0.56 6.90 55,314 9,953,902
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		P - Purchase 590 13,667 4.51 8.00 4,720 109,336
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		P - Purchase 61,910 1,435,202 4.51 8.00 495,280 11,481,616
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		P - Purchase 5,653 13,077 76.14 8.00 45,224 104,616
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		P - Purchase 593,618 1,373,292 76.14 8.00 4,748,944 10,986,336
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		C - Conversion 1,730 7,424 30.38
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		C - Conversion 181,689 779,674 30.38
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		C - Conversion 2,094 5,694 58.17
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		C - Conversion 219,863 597,985 58.15
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		C - Conversion 3,498 3,600 3,429.41
2013-05-22 2013-05-21 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		C - Conversion 367,315 378,122 3,398.86
2013-05-22 2013-05-20 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		P - Purchase 100 102 5,000.00 6.78 678 691
2013-05-22 2013-05-20 4 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		P - Purchase 10,500 10,807 3,420.20 6.78 71,162 73,242
2013-05-15 3 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		307
2013-05-15 3 AMBI AMBIT BIOSCIENCES CORP
Common Stock, $0.001 par value per share 		2
2012-09-05 2012-09-04 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares 		S - Sale X -2,244 5,700 -28.25 14.43 -32,388 82,268
2012-09-05 2012-09-04 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares 		S - Sale X -231,456 594,300 -28.03 14.43 -3,340,604 8,577,532
2012-07-30 2012-07-27 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares 		S - Sale X -3,456 7,944 -30.32 14.61 -50,483 116,041
2012-07-30 2012-07-27 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares 		S - Sale X -362,844 825,756 -30.53 14.61 -5,300,207 12,062,148
2012-07-13 2012-07-13 4 GNOM COMPLETE GENOMICS INC
Common Stock 		S - Sale -4,500 27,859 -13.91 2.51 -11,298 69,943
2012-07-13 2012-07-13 4 GNOM COMPLETE GENOMICS INC
Common Stock 		S - Sale -474,800 2,922,141 -13.98 2.51 -1,192,033 7,336,327
2012-07-13 2012-07-12 4 GNOM COMPLETE GENOMICS INC
Common Stock 		S - Sale -2,076 32,359 -6.03 2.85 -5,916 92,210
2012-07-13 2012-07-12 4 GNOM COMPLETE GENOMICS INC
Common Stock 		S - Sale -218,624 3,396,941 -6.05 2.85 -622,991 9,679,923
2012-07-13 2012-07-11 4 GNOM COMPLETE GENOMICS INC
Common Stock 		S - Sale -4,792 34,435 -12.22 2.90 -13,891 99,820
2012-07-13 2012-07-11 4 GNOM COMPLETE GENOMICS INC
Common Stock 		S - Sale -503,144 3,615,565 -12.22 2.90 -1,458,514 10,480,800
2012-06-19 2012-06-19 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares 		S - Sale -5,900 11,400 -34.10 12.91 -76,185 147,205
2012-06-19 2012-06-19 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares 		S - Sale -611,200 1,188,600 -33.96 12.91 -7,892,242 15,348,035
2012-03-13 2012-03-12 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -700 2,446,000 -0.03 11.03 -7,722 26,983,783
2012-03-13 2012-03-12 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -62,400 2,446,700 -2.49 11.03 -688,384 26,991,505
2012-03-13 2012-03-09 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -300 2,509,100 -0.01 11.25 -3,374 28,216,335
2012-03-13 2012-03-09 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -36,700 2,509,400 -1.44 11.25 -412,714 28,219,709
2012-02-29 2012-02-29 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -3,000 2,546,100 -0.12 10.86 -32,584 27,654,211
2012-02-29 2012-02-28 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -100 2,549,100 0.00 11.12 -1,112 28,347,012
2012-02-29 2012-02-28 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -10,000 2,549,200 -0.39 11.12 -111,204 28,348,124
2012-02-29 2012-02-27 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -300 2,559,200 -0.01 11.05 -3,314 28,271,994
2012-02-29 2012-02-27 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -28,700 2,559,500 -1.11 11.05 -317,055 28,275,308
2012-02-03 2012-02-03 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -500 2,588,200 -0.02 10.79 -5,395 27,927,713
2012-02-03 2012-02-03 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -49,500 2,588,700 -1.88 10.79 -534,125 27,933,108
2012-02-03 2012-02-02 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -200 2,638,200 -0.01 10.85 -2,171 28,637,133
2012-02-03 2012-02-02 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -23,100 2,638,400 -0.87 10.85 -250,746 28,639,304
2012-02-03 2012-02-01 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -700 2,661,500 -0.03 11.01 -7,704 29,291,937
2012-02-03 2012-02-01 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -69,300 2,662,200 -2.54 11.01 -762,702 29,299,641
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)